TKNO
Alpha Teknova, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$7.79
+4.56%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$7.34
From 52W high+0.00%
Volume501712.00
Market cap$418.23M
P/E (TTM)—
P/S (TTM)9.6x
Div yield—
Key dataSep 18, 2026
Open
$7.34
From 52W high
+0.00%
Volume
501712.00
Market cap
$418.23M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−45.3x
P/E (TTM)
—
RSI (14)
63.7
MomentumView details →
1D Return
+4.56%
YTD Return
+98.34%
SummaryUpdated Jun 1, 2026
Alpha Teknova, Inc. (NASDAQ:TKNO) is a California-based life sciences company founded in 1996 that provides critical reagents and laboratory consumables to the biotechnology and pharmaceutical industries. The company went public in June 2021 and is headquartered in Hollister, California. Alpha Teknova specializes in manufacturing high-quality reagents that enable the discovery, development, and production of biopharmaceutical products including drug therapies, vaccines, and molecular diagnostics.
Similar companies
Latest newsMore news →
Teknova launched the Fill-Tek Dispensing System, a custom manufacturing offering for filling single-use bag orders across multiple sizes and quantities as a single lot.4d agoBrett Robertson was elected as a Class II director of Alpha Teknova, Inc., effective June 1, 2026.112d agoJ. Matthew Mackowski was elected as a Class II director of Alpha Teknova, Inc., effective June 1, 2026.112d ago